Supriya Lifescience clarifies it is a distinct entity from Supriya Pharmaceuticals, with no operational affiliation or control over its shareholder services.

This addresses recent investor queries regarding share dematerialization for Supriya Pharmaceuticals.

Supriya Lifescience confirms all its shares are in Demat form, with zero physical shareholding.

Shareholders of Supriya Pharmaceuticals should directly contact that company for any dematerialization requests or related matters, as Supriya Lifescience is not responsible for those shares.

This aims to prevent investor confusion.